Cellebrite DI Ltd (NASDAQ: CLBT) is 6.31% higher on its value in year-to-date trading and has touched a low of $8.73 and a high of $24.18 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CLBT stock was last observed hovering at around $23.87 in the last trading session, with the day’s loss setting it -0.45%.
Currently trading at $23.42, the stock is 4.57% and 12.50% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.69 million and changing -1.89% at the moment leaves the stock 48.95% off its SMA200. CLBT registered 162.26% gain for a year compared to 6-month gain of 72.97%. The firm has a 50-day simple moving average (SMA 50) of $20.7261 and a 200-day simple moving average (SMA200) of $15.662925.
The stock witnessed a 10.00% loss in the last 1 month and extending the period to 3 months gives it a 29.04%, and is 2.23% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.50% over the week and 3.49% over the month.
Cellebrite DI Ltd (CLBT) has around 1008 employees, a market worth around $4.87B and $385.17M in sales. Fwd P/E is 90.58. Profit margin for the company is -82.28%. Distance from 52-week low is 168.27% and -3.15% from its 52-week high. The company has generated returns on investments over the last 12 months (-103.53%).
with sales reaching $107.26M over the same period.The EPS is expected to shrink by -218.60% this year, but quarterly earnings will post 22.85% year-over-year. Quarterly sales are estimated to grow 15.31% in year-over-year returns.
221.0 institutions hold shares in Cellebrite DI Ltd (CLBT), with institutional investors hold 99.83% of the company’s shares. The shares outstanding are 208.08M, and float is at 86.02M with Short Float at 1.36%. Institutions hold 53.12% of the Float.
The top institutional shareholder in the company is TRUE WIND CAPITAL MANAGEMENT, L.P. with over 13.39 million shares valued at $159.98 million. The investor’s holdings represent 6.8018 of the CLBT Shares outstanding. As of 2024-06-30, the second largest holder is CLAL INSURANCE ENTERPRISES HOLDINGS LTD with 7.65 million shares valued at $91.47 million to account for 3.8892 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 6.99 million shares representing 3.5519 and valued at over $83.54 million, while NINE TEN CAPITAL MANAGEMENT LLC holds 1.9935 of the shares totaling 3.92 million with a market value of $46.89 million.
Cellebrite DI Ltd (CLBT) Insider Activity
Still, SEC filings show that on Dec 11 ’24, Aliazar Keinan (Director) Proposed Sale 19,385 shares at an average price of $19.89 for $0.39 million. The insider now directly holds shares of Cellebrite DI Ltd (CLBT).
